FindTrial
Sign In

Study Of Blood Pressure Medicines And Assessment Of Mother And Newborn Outcomes In Pregnant Women With Hypertension.

Prescription Pattern Of Antihypertensive Medications And Assessment Of Maternal And Neonatal Outcomes In Pregnant Women With Hypertension: A Retrospective Observational Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/092788
Enrollment
360
Registered
2025-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O169- Unspecified maternal hypertension,unspecified trimester

Interventions

Intervention1: Nil: Nil

Sponsors

NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age greater than and equal to 18years Pregnant patients with hypertension Singleton pregnancies Women receiving antenatal care at the study hospital

Exclusion criteria

Exclusion criteria: Multiple pregnancies (twins or more) With comorbidities (diabetes mellitus)

Design outcomes

Primary

MeasureTime frame
To provide insights into prescribing trends based on gestational age and severity of hypertension.Timepoint: Eight Months—

Secondary

MeasureTime frame
To recognize the maternal and neonatal outcomes among pregnant women with hypertension .Timepoint: Eight Months—

Countries

India

Contacts

Public ContactDr Roopa Satyanarayan Basutkar

NGSM Institute of Pharmaceutical Sciences

roopa.satyanarayan@nitte.edu.in9047155003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026